✦ LIBER ✦

Combined α/β-Blockade: An Underused Approach to the Treatment of Resistant Hypertension

✍ Scribed by Samuel J. Mann

Book ID: 115306551
Publisher: Le Jacq Communications, Inc.
Year: 2007
Tongue: English
Weight: 103 KB
Volume: 9
Category: Article
ISSN: 1524-6175
DOI: 10.1111/j.1524-6175.2007.07225.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

β-Blockers in Hypertension: A Reassessme

β-Blockers in Hypertension: A Reassessment of the Benefit of Combined α-/β-Blockade

✍ Domenic A. Sica 📂 Article 📅 2007 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 126 KB

Low-dose α/β blockade in the treatment o

Low-dose α/β blockade in the treatment of essential hypertension

✍ Samuel J Mann; Linda M Gerber 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 189 KB

An approach to the treatment of essentia

An approach to the treatment of essential hypertension

✍ Nicolas D. Vlachakis; Milton Mendlowitz 📂 Article 📅 1976 🏛 Elsevier Science 🌐 English ⚖ 689 KB

Labetalol, an α- and β-adrenergic blocki

Labetalol, an α- and β-adrenergic blocking drugin the treatment of hypertension

✍ E. Agabiti Rosei; R. Fraser; J.J. Morton; J.J. Brown; A.F. Lever; J.I.S. Roberts 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 211 KB

Association of the stimulatory G-protein

Association of the stimulatory G-protein α-subunit gene with essential hypertension and response to β-blockade

✍ H. Jia; A. Hingorani; P. Sharma; R. Hopper; M.J. Brown 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 80 KB

Calcium-channel blockade (nitrendipine)

Calcium-channel blockade (nitrendipine) in combination with ACE inhibition (captopril) in the treatment of mild to moderate hypertension

✍ Carlo Gennari; Renato Nami; Giovanni Pavese; Stefania Gragnani; Claudio Bianchin 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 545 KB

## CALCIUM-CHANNEL BLOCKADE I NITRENDIPINE) IN COMBINATION WITH ACE NHIBITION {CAPTOPRIL)IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION SUMMARY. The antihypertensive efficacy of a combination of calcium-channel blockers and angiotensin-converting-enzyme (ACE) inhibitors in severe primary hypert